Prevalence of oral and oropharyngeal human papillomavirus infection in Brazilian population studies: a systematic review
- PMID: 26248966
- PMCID: PMC9449068
- DOI: 10.1016/j.bjorl.2015.04.001
Prevalence of oral and oropharyngeal human papillomavirus infection in Brazilian population studies: a systematic review
Abstract
Introduction: Human papillomavirus has been associated with head and neck squamous cell carcinoma. However, there is no conclusive evidence on the prevalence of oral or pharyngeal infection by human papillomavirus in the Brazilian population.
Objective: To determine the rate of human papillomavirus infection in the Brazilian population.
Methods: Systematic review of published articles. Medline, The Cochrane Library, Embase, Lilacs (Latin American and Caribbean Health Sciences) and Scielo electronic databases were searched. The search included published articles up to December 2014 in Portuguese, Spanish and English. A wide search strategy was employed in order to avoid publication biases and to assess studies dealing only with oral and/or oropharyngeal human papillomavirus infections in the Brazilian population.
Results: A total of 42 articles included 4066 enrolled patients. It was observed that oral or oropharyngeal human papillomavirus infections were identified in 738 patients (18.2%; IC 95 17.6-18.8), varying between 0.0% and 91.9%. The prevalences of oral or oropharyngeal human papillomavirus infections were respectively 6.2%, 44.6%, 44.4%, 27.4%, 38.5% and 11.9% for healthy people, those with benign oral lesions, pre-malignant lesions, oral or oropharyngeal squamous cell carcinoma, risk groups (patients with genital human papillomavirus lesions or infected partners) and immunocompromised patients. The risk of human papillomavirus infection was estimated for each subgroup and it was evident that, when compared to the healthy population, the risk of human papillomavirus infection was approximately 1.5-9.0 times higher, especially in patients with an immunodeficiency, oral lesions and squamous cell carcinoma. The rates of the most well-known oncogenic types (human papillomavirus 16 and/or 18) also show this increased risk.
Conclusions: Globally, the Brazilian healthy population has a very low oral human papillomavirus infection rate. Other groups, such as at-risk patients or their partners, immunocompromised patients, people with oral lesions and patients with oral cavity or oropharyngeal squamous cell carcinoma have a high risk of human papillomavirus infection.
Introdução: O papilomavírus humano (HPV) tem sido associado ao carcinoma de células escamosas (CCE) de cabeça e pescoço. No entanto, não existem evidências conclusivas sobre a prevalência de infecção oral ou faríngea pelo HPV na população brasileira.
Objetivo: Determinar a taxa de infecção pelo HPV na população brasileira.
Método: Revisão sistemática de artigos publicados. Foram feitas buscas nos seguintes bancos de dados eletrônicos: Medline, The Cochrane Library, Embase, Lilacs (Latin American and Caribbean Health Sciences) e Scielo. A busca considerou artigos publicados até dezembro de 2014, em português, espanhol e inglês. Foi utilizada uma ampla estratégia de busca com o intuito de evitar viés de publicação e também para que fossem avaliados estudos que tratassem apenas de infecções orais e/ou orofaríngeas pelo HPV na população brasileira.
Resultados: Os 42 artigos selecionados incluíram 4.066 pacientes. Observou-se que infecções orais ou orofaríngeas pelo HPV foram identificadas em 738 pacientes (18,2%; IC95 17,6-18,8), variando entre 0,0-91,9%. As prevalências de infecções orais ou orofaríngeas pelo HPV foram, respectivamente, 6,2%, 44,6%, 44,4%, 27,4%, 38,5% e 11,9% em pacientes saudáveis, com lesões orais benignas, com lesões pré-malignas, com CCE oral ou orofaríngeo, grupos de risco (pacientes com lesões genitais pelo HPV ou parceiros infectados) e pacientes imunodeficientes. O risco de infecção pelo HPV foi estimado para cada subgrupo, quando ficou evidente que, em comparação com a população saudável, o risco de infecção por HPV foi aproximadamente 1,5-9,0 vezes mais alto, especialmente em pacientes com imunodeficiência, lesões orais e CCE. Os percentuais dos tipos oncogênicos mais conhecidos (HPV 16 e/ou 18) também mostram esse aumento no risco.
Conclusões: A população brasileira saudável apresenta taxa de infecção oral pelo HPV muito baixa. Outros grupos, por exemplo, pacientes de risco ou seus parceiros, pacientes imunodeficientes, indivíduos portadores de lesões orais e pacientes com CCE de cavidade oral ou orofaringe apresentam maior risco de infecção pelo HPV.
Keywords: Boca; Brasil; Brazil; Human papillomavirus; Mouth; Orofaringe; Oropharynx; Papilomavírus humano; Prevalence; Prevalência.
Copyright © 2015 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved.
Figures
Similar articles
-
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD010341. doi: 10.1002/14651858.CD010341.pub2. Cochrane Database Syst Rev. 2015. PMID: 26625332 Free PMC article.
-
Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Cochrane Database Syst Rev. 2010. PMID: 21069679 Free PMC article.
-
Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.Cochrane Database Syst Rev. 2016 Dec 11;12(12):CD010963. doi: 10.1002/14651858.CD010963.pub2. Cochrane Database Syst Rev. 2016. PMID: 27943254 Free PMC article.
-
Population-based interventions for reducing sexually transmitted infections, including HIV infection.Cochrane Database Syst Rev. 2004;(2):CD001220. doi: 10.1002/14651858.CD001220.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001220. doi: 10.1002/14651858.CD001220.pub3. PMID: 15106156 Updated.
-
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780. Cochrane Database Syst Rev. 2024. PMID: 39679851 Free PMC article.
Cited by
-
Cancer in the head and neck region and its face under the perspective of users of a public reference hospital in Recife, state of Pernambuco, Brazil.Braz J Otorhinolaryngol. 2025 Jul;91 Suppl 1(Suppl 1):101601. doi: 10.1016/j.bjorl.2025.101601. Epub 2025 Jun 4. Braz J Otorhinolaryngol. 2025. PMID: 40472631 Free PMC article.
-
Characterization of high risk human papilloma virus genotypes associated with oropharyngeal cancers in a Nigerian population.Pan Afr Med J. 2021 Jan 15;38:40. doi: 10.11604/pamj.2021.38.40.27309. eCollection 2021. Pan Afr Med J. 2021. PMID: 33777308 Free PMC article.
-
STOP HPV study protocol: a nationwide case-control study of the association between oropharyngeal cancer and human papillomavirus (HPV) infection in Brazil.BMJ Open. 2020 Jan 29;10(1):e031602. doi: 10.1136/bmjopen-2019-031602. BMJ Open. 2020. PMID: 32001492 Free PMC article.
-
Prevalence and Genotyping of HPV in Oral Squamous Cell Carcinoma in Northern Brazil.Pathogens. 2022 Sep 27;11(10):1106. doi: 10.3390/pathogens11101106. Pathogens. 2022. PMID: 36297163 Free PMC article.
-
The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.PLoS One. 2020 May 14;15(5):e0232871. doi: 10.1371/journal.pone.0232871. eCollection 2020. PLoS One. 2020. PMID: 32407339 Free PMC article.
References
-
- Sanders A.E., Slade G.D., Patton L.L. National prevalence of oral HPV infection and related risk factors in the U.S. adult population. Oral Dis. 2012;18:430–441. - PubMed
-
- Matos L.L., Manfro G., Santos R.V., Stabenow E., Mello E.S., Alves V.A., et al. Tumor thickness as a predictive factor of lymph node metastasis and disease recurrence in T1N0 and T2N0 squamous cell carcinoma of the oral tongue. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:209–217. - PubMed
-
- Pinto F.R., de Matos L.L., Palermo F.C., Kulcsar M.A., Cavalheiro B.G., de Mello E.S., et al. Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2014;271:1747–1754. - PubMed
-
- Miller C.S., Johnstone B.M. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:622–635. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources